Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

FT US Equity Opportunities ETF (NY: FPX )

98.99 -0.39 (-0.39%)
Streaming Delayed Price Updated: 2:59 PM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about FT US Equity Opportunities ETF

< Previous 1 2 3 Next >
Freshworks Seeks $9.6B Valuation In Upsized US IPO
Customer relationship management (CRM) solution provider Freshworks Inc (NASDAQ: FRSH) now plans to sell 28.5 million shares for $32 - $34 per share in an upsized... 
Via Benzinga
Toast Targets $18B Valuation In Upsized US IPO
Restaurant Software firm Toast Inc (NYSE: TOST) now plans to sell 21.7 million shares for $34 - $36 per share in an upsized initial public offering. The... 
Via Benzinga
Gaming Hardware Company Seeks Secondary Listing In US: CNBC
Gaming hardware company Razer Inc (OTC: RAZFF) harbors secondary listing ambitions in the U.S., CNBC reports as per CEO Min-Liang Tan. The laptop and PC... 
Via Benzinga
Chinese EV Firm Aiways Targets US IPO: Bloomberg
Shanghai EV startup, Aichi Automobile Co, also known as Aiways, is looking to raise around $300 million via a U.S. initial public offering, Bloomberg reports. The... 
Via Benzinga
Invest in Robinhood With These ETFs
Given the meme stock craze, investors could easily tap this newly minted company with ETFs. A few have already fast-filled the trading app and some will add Robinhood to their roster in the coming... 
Via Talk Markets
IDW Media Raises $9M Via Equity Offering, Uplists To NYSE Today
Media company IDW Media Holdings, Inc (NYSE: IDW) priced 2.5 shares at $3.60 per share to raise $9.0 million in the initial public offering. The offer price... 
Via Benzinga
Adagio Therapeutics Sets Terms For Over $300M IPO
Adagio Therapeutics (NASDAQ: ADGI) has set terms for the IPO, looking to raise well north of $300 million if they hit the top of the $16 to $18 range. Since its... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
XPO Logistics Spinoff GXO Logistics To Ring NYSE Opening Bell On Monday
XPO Logistics Inc's (NYSE: XPO) logistics segment spin-off, GXO Logistics (NYSE: GXO), is slated for debut on August 2, 2021. The executive team and members of the board of... 
Via Benzinga
Oncology-Focused Biotech Immuneering Jumps To Wall Street With $112M IPO
Immuneering Corp (NASDAQ: IMRX) has kept a relatively low profile since launching with $17 million back in 2019. That is until it landed another $62 million ... 
Via Benzinga
Omega Therapeutics Kicks Start Trading On NASDAQ
On the heels of a $126 million crossover round in March, Flagship Pioneering-backed Omega Therapeutics Inc (NASDAQ: OMGA) has priced a $125.8 million IPO to take... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
London-Listed MaxCyte Makes NASDAQ Debut Today
MaxCyte Inc (NASDAQ: MXCT) is already trading on London’s AIM, but now, it debuted on NASDAQ after pricing a $176 million IPO at $13 apiece, on the higher end of... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
PowerSchool Raises $710.5M Via IPO At $18 Per Share, Trading Begins Today
The cloud-based software provider for K-12 education in North America PowerSchool Holdings, Inc, (NYSE: PWSC) priced 39.5 million shares at $18 per share in its ... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Language Learning App Duolingo Could Be Valued Over $4.6B Based On Upsized IPO: Reuters
Duolingo Inc (NASDAQ: DUOL) proposed to sell 5.1 million shares at between $95 - $100 each in its upsized U.S. initial public offering, Reuters reports. The hike... 
Via Benzinga
Cell Analysis Instruments Provider Cytek Biosciences Kick Starts Trading After Pricing IPO At $17
Cytek Biosciences Inc (NASDAQ: CTKB) shares started trading today after its initial public offering was priced to raise about $200 million for the cell-analysis Company.... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Xponential Fitness Prices Downsized IPO Below Expected Range
Xponential Fitness Inc (NYSE: XPOF), a fitness franchiser, has announced the pricing of its initial public offering (IPO) of 10 million shares at $12 per ordinary... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Outbrain Prices IPO Below Expected Range; Trading Begins Today
Open web recommendation platform Outbrain Inc (NASDAQ: OB) priced 8 million shares at $20 per share in its initial public offering. It earlier expected to price... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Gambling.com Prices IPO At Lower End Of Expected Range
Gambling.com Group Ltd (NASDAQ: GAMB), a digital marketing services provider, has announced the pricing of its initial public offering (IPO) of 5.25 million shares... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
AI-based Healthcare Data Analytics Platform Provider Sophia Genetics Makes Its Wall Street Debut: What You Need to Know
Switzerland-based Sophia Genetics SA (NASDAQ: SOPH), a healthcare tech company, is debuting on Wall Street Friday. Here is what you should know about the company. Sophia... 
Via Benzinga
Instructure Holdings Raises $250M Via IPO At $20 Per Share, Trading Begins Today
Education technology company Instructure Holdings Inc (NYSE: INST) priced 12.5 million shares at $20 per share in its initial public offering. It earlier... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Zenvia Raises $150M Via IPO At $13 Per Share
Customer experience communications platform Zenvia Inc (NASDAQ: ZENV) priced 11.5 million shares at $13 per share in its initial public offering. The... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
VTEX Raised $264M Via IPO At $19 Per Share, Trading Begins Today
Software-as-a-service digital commerce platform provider VTEX (NYSE: VTEX) priced 19 million shares at $19 per share in its initial public offering. The... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Paycor HCM Raised $425.5M Via IPO At $23 Per Share, Trading Begins Today
Human Capital Management (HCM) software creator Paycor HCM Inc (NASDAQ: PYCR) priced 18.5 million shares at $23 per share in its initial public offering. The... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Nervous System Firm Eliem Therapeutics Files For $80M IPO
Eliem Therapeutics (NASDAQ: ELYM), a Phase 2a biotech developing therapies for neuronal excitability disorders, filed an IPO prospectus with the SEC to raise up to $80... 
Via Benzinga
Topics Initial Public Offering Regulatory Compliance
Exposures Legal Regulatory Securities Market
Skin-Disease Focused Biotech Castle Creek Files $100M IPO
Ahead of Phase 3 data readout in the second half of next year, Castle Creek Biosciences Inc (NASDAQ: CCBS) seeks to make NASDAQ debut under the symbol CCBS. The Company... 
Via Benzinga
Adagio Files $100M IPO To Take Its COVID-19 Antibody Through Commercialization In 2022
Adagio Therapeutics has filed an initial public offering to raise money to bring its COVID-19 antibody to market. The $100 million IPO will support Phase 2/3 trials... 
Via Benzinga
Topics Initial Public Offering
Exposures COVID-19 Securities Market
Celularity Closes SPAC Merger With GX Acquisition, Trading Starts Monday
Celularity Inc has closed the merger with GX Acquisition Corp (NASDAQ: GXGX), giving Celularity $138 million to push the NK cell and T cell therapies into early-... 
Via Benzinga
Alibaba, SoftBank Backed Indian Online Payment Startup Paytm Eyes $2.2B IPO: TechCrunch
Indian digital payments startup, Paytm, plans to raise $2.2 billion in an initial public offering, TechCrunch reports. Alibaba Group Holding Ltd (NYSE: BABA) and Ant... 
Via Benzinga
Heart Disease Company Tenaya Therapeutics Files For $100M US IPO
Tenaya Therapeutics (NASDAQ: TNYA) is quickstepping into a $100 million NASDAQ debut under the TNYA symbol. The company filed an SEC prospectus on Friday. The biotech... 
Via Benzinga
Topics Regulatory Compliance
Exposures Legal Regulatory
Ocular Medical Device Firm Sight Sciences Sets Terms For $150M IPO
Ophthalmic device developer Sight Sciences (NASDAQ: SGHT) hopes to see its way to nearly a $1 billion valuation through a $150 million Nasdaq debut. The IPO includes 7... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Precision Oncology-Focused Biotech Nuvalent Files For $100M IPO
Less than six months after emerging from stealth, the Deerfield-backed biotech Nuvalent (NASDAQ: NUVL) is already prepping a Nasdaq debut. Nuvalent filed its S-1... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.